Alert
FDA Alert: Olaax Corp. Issues a Nationwide Voluntary Recall of All Lots of Maxiloss Weight Advanced Softgels Dietary Supplement
Health Care Provider Alert: Another Counterfeit Cancer Medicine Found in United States
This is a reprint of an FDA Alert. Purchasing Unapproved Drugs is Risky Business [2/5/2013] The Food and Drug Administration is committed to protecting the supply chain against counterfeit and unapproved medicines that enter the United States through fraudulent sources. As part of this vigilance, FDA is alerting health care professionals that an unapproved cancer…
[...]Voluntary Nationwide Recall of Super Power Due to Undeclared, Potentially Hazardous Active Ingredient
This is a reprint of an FDA Alert Recall — Firm Press Release FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. Freedom Trading Issues a Voluntary…
[...]Reumofan Plus Relabeled and Sold as WOW
This is a reprint of an FDA Alert. The U.S. Food and Drug Administration (FDA) is warning the public that the potentially harmful product Reumofan Plus, marketed as a dietary supplement, is being relabeled and sold under the name “WOW.” The product is being marketed to treat arthritis, muscle pain, osteoporosis, bone cancer, and other…
[...]Products Recalled Due to Undeclared Sildenafil Analogues
This is a reprint of an FDA Alert. Recall — Firm Press Release FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. Recall – Performance Plus Marketing…
[...]FDA Alert: Voluntary Nationwide Recall Of Classic Zi Xiu Tang Bee Pollen Capsules And Ultimate Formula Capsules Due To Undeclared Sibutramine
This is a reprint of an FDA Alert. Recall — Firm Press Release FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. Zi Xiu Tang Success, LLC…
[...]FDA Alert: Multistate outbreak of fungal meningitis and other infections
Multistate outbreak of fungal meningitis and other infections. FDA provides NECC Customer List. Ameridose recalls all products. This is a summary of the FDA Alerts on fungal meningitis and bacterial contamination in New England Compounding Center (NECC) products and recall of Ameridose products. Bacterial contamination also found in NECC Products. [11-01-2012] The U.S. Food and…
[...]FDA Alert: Dietary Supplements Recalled Because of Undeclared Ingredients
Dietary Supplements Mojo Nights and Mojo Nights for HerFDA Recalls via FDA Website. This is a reprint of an FDA Alert. FDA Alert: Evol Nutrition Associates, Inc./ Red Dawn Issues Voluntary Nationwide Recall of Dietary Supplements Mojo Nights and Mojo Nights for Her Because of Potential Health Risk FOR IMMEDIATE RELEASE – August 23,…
[...]FDA Alert: Body Basics Inc. Issues a Voluntary Nationwide Recall of ACTRA-Sx 500 Capsules, Lot 008-A, due to Potential Health Risks
This is a reprint of an FDA press release. FOR IMMEDIATE RELEASE – September 12, 2012 – Body Basics Inc. announced today that it is conducting a voluntary nationwide recall of ACTRA-Sx 500 Dietary Supplement Capsules, Lot 008-A, Expiration December 2013. The Company, through independent lab analysis has confirmed the presence of Sildenafil Citrate making…
[...]FDA Alert: Intestinomicina (contains chloramphenicol) by Laboratorios Lopez: Safety Alert – Contains Drug Ingredient Withdrawn from US
FDA is warning consumers not to purchase or use Intestinomicina, a drug marketed for infectious diarrhea, due to its containing unnaproved and dangerous ingredients. A quick Google search by PSM turned up several Spanish-language websites offering the drug for sale. This is a reprint of an FDA Alert. AUDIENCE: Consumer, Health Professional ISSUE: FDA is…
[...]